Baxter On A Roll -- Wins Approval For OBIZUR
October 24, 2014 at 18:31 PM EDT
Baxter continues to enhance its growth prospects prior to the spin-off in 2015. The latest approval for OBIZUR corroborates this position.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.